In this work, our aim was to investigate a wider de-regulation for FAM83H-AS1 expression in tumors, focusing on its functional and clinical role in breast cancer and the identification of potential FAM83H-AS1 targets. This evidence concerns the gene SACK1H and breast carcinoma.